Soltis Investment Advisors »

Galectin Therapeutics shares owned by Soltis Investment Advisors

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Soltis Investment Advisors from 13F filings

Historical chart of Soltis Investment Advisors investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Soltis Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Soltis Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $182k 141k 1.29
2024-09-30 $387k 141k 2.75

More positions owned by Soltis Investment Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Security Natl Finl Corp Cl A New (SNFCA)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Ishares Tr Core S&p Mcp Etf (IJH)
Innovator Etfs Trust Equity Defined P
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Admiral Fds Midcp 400 Idx (IVOO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Soltis Investment Advisors

Top funds holding Galectin Therapeutics

Affinity Asset Advisors
Ikarian Capital
Vanguard Group
Susquehanna International
BlackRock
Advisor Group Holdings
Geode Capital Management
Boothbay Fund Management
Citadel Advisors
Caption Management
Sontag Advisory
Geneos Wealth Management
Morgan Stanley
State Street Corporation
Northern Trust

View all funds holding Galectin Therapeutics